文献库搜索 | GeneLibs

Ren(Yi A),Mullany(Lisa K),Liu(Zhilin),Herr... Cancer Res 0000-00-00

...TP53 transactivation activity but retained responsiveness to nutlin-3a, an activator of WT TP53. Moreover, high levels o...

Deng(Changkai),Dai(Rong),Li(Xuliang),Liu(F... Cancer Sci 0000-00-00

...TP53, MYCN, DROSHA, and DGCR8 was 0.141 (0.104, 0.178), 0.147 (0.110, 0.184), 0.140 (0.100, 0.190), 0.410 (0.214, 0.605)...

Rodríguez-Hernández(Carlos J),Mateo-Lozano... Oncotarget 0000-00-00

...TP53 status. In vitro, acute exposure to cinacalcet induced endoplasmic reticulum stress coupled to apoptosis via ATF4-C...

Frenzel(Lukas P),Reinhardt(H Christian),Pa... Oncol Res Treat 0000-00-00

...TP53 and ATM are frequent events in chemotherapy-naïve patients and are further enriched in chemotherapy-resistant patie...

Cramer(Paula),Hallek(Michael),Eichhorst(Ba... Oncol Res Treat 0000-00-00

...TP53 mutation: Physically fit patients without or with only mild comorbidities should receive fludarabine, cyclophospham...

Tausch(Eugen),Mertens(Daniel),Stilgenbauer... Oncol Res Treat 0000-00-00

...TP53 mutation status are well-established and essential to discriminate between a more indolent course of disease and a ...

Katoh(Iyoko),Fukunishi(Nahoko),Fujimuro(Ma... Cell Cycle 0000-00-00

...TP53 (p53) gene family, is expressed in keratinocyte stem cells and well-differentiated squamous cell carcinomas to main...

Sasaki(Yasushi),Tamura(Miyuki),Koyama(Ryot... World J Gastroenterol 0000-00-00

...TP53, CDKN2A, FAT1, NOTCH1, PIK3CA, KMT2D and NFE2L2, which had been previously implicated in ESCC. Several new recurren...

Chang(Yuli Christine),Chang(Jan-Gowth),Liu... World J Gastroenterol 0000-00-00

...TP53 that have not been previously reported. Additionally, we found 16 de novo mutations in APC, BMPR1A, MLH1, MSH2, MSH...

Dieci(Maria Vittoria),Smutná(Veronika),Sco... Breast Cancer Res Treat 0000-00-00

...TP53, GATA3, and MAP2K4 were the most frequently mutated genes. Metaplastic BCs presented a high frequency of TP53 (78 %...